BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 30575523)

  • 1. A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement.
    Wang X; Piersma SJ; Nelson CA; Dai YN; Christensen T; Lazear E; Yang L; Sluijter M; van Hall T; Hansen TH; Yokoyama WM; Fremont DH
    Elife; 2018 Dec; 7():. PubMed ID: 30575523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral infection modulates Qa-1b in infected and bystander cells to properly direct NK cell killing.
    Ferez M; Knudson CJ; Lev A; Wong EB; Alves-Peixoto P; Tang L; Stotesbury C; Sigal LJ
    J Exp Med; 2021 May; 218(5):. PubMed ID: 33765134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of functional Cd94 polymorphism in a free-living house mouse population.
    Knutsen LE; Dissen E; Saether PC; Bjørnsen EG; Piálek J; Storset AK; Boysen P
    Immunogenetics; 2019 Apr; 71(4):321-333. PubMed ID: 30535636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
    Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
    Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nonclassical MHC class I molecule Qa-1 forms unstable peptide complexes.
    Kambayashi T; Kraft-Leavy JR; Dauner JG; Sullivan BA; Laur O; Jensen PE
    J Immunol; 2004 Feb; 172(3):1661-9. PubMed ID: 14734748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the murine CD94-NKG2A receptor in complex with Qa-1
    MacLachlan BJ; Sullivan LC; Brooks AG; Rossjohn J; Vivian JP
    FEBS J; 2024 Apr; 291(7):1530-1544. PubMed ID: 38158698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic inhibition of natural killer cells by the nonsignaling molecule CD94.
    Cheent KS; Jamil KM; Cassidy S; Liu M; Mbiribindi B; Mulder A; Claas FH; Purbhoo MA; Khakoo SI
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16981-6. PubMed ID: 24082146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse CD94 participates in Qa-1-mediated self recognition by NK cells and delivers inhibitory signals independent of Ly-49.
    Toyama-Sorimachi N; Taguchi Y; Yagita H; Kitamura F; Kawasaki A; Koyasu S; Karasuyama H
    J Immunol; 2001 Mar; 166(6):3771-9. PubMed ID: 11238619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.
    Lu L; Ikizawa K; Hu D; Werneck MB; Wucherpfennig KW; Cantor H
    Immunity; 2007 May; 26(5):593-604. PubMed ID: 17509909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b.
    Zeng L; Sullivan LC; Vivian JP; Walpole NG; Harpur CM; Rossjohn J; Clements CS; Brooks AG
    J Immunol; 2012 Jan; 188(1):302-10. PubMed ID: 22131332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blastocyst MHC, a putative murine homologue of HLA-G, protects TAP-deficient tumor cells from natural killer cell-mediated rejection in vivo.
    Tajima A; Tanaka T; Ebata T; Takeda K; Kawasaki A; Kelly JM; Darcy PK; Vance RE; Raulet DH; Kinoshita K; Okumura K; Smyth MJ; Yagita H
    J Immunol; 2003 Aug; 171(4):1715-21. PubMed ID: 12902470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.
    Heatley SL; Pietra G; Lin J; Widjaja JML; Harpur CM; Lester S; Rossjohn J; Szer J; Schwarer A; Bradstock K; Bardy PG; Mingari MC; Moretta L; Sullivan LC; Brooks AG
    J Biol Chem; 2013 Mar; 288(12):8679-8690. PubMed ID: 23335510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rat and mouse CD94 associate directly with the activating transmembrane adaptor proteins DAP12 and DAP10 and activate NK cell cytotoxicity.
    Saether PC; Hoelsbrekken SE; Fossum S; Dissen E
    J Immunol; 2011 Dec; 187(12):6365-73. PubMed ID: 22084441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NKG2A/CD94 Is a New Immune Receptor for HLA-G and Distinguishes Amino Acid Differences in the HLA-G Heavy Chain.
    Hò GT; Celik AA; Huyton T; Hiemisch W; Blasczyk R; Simper GS; Bade-Doeding C
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
    Nielsen N; Pascal V; Fasth AE; Sundström Y; Galsgaard ED; Ahern D; Andersen M; Baslund B; Bartels EM; Bliddal H; Feldmann M; Malmström V; Berg L; Spee P; Söderström K
    Immunology; 2014 Aug; 142(4):581-93. PubMed ID: 24673109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orderly and nonstochastic acquisition of CD94/NKG2 receptors by developing NK cells derived from embryonic stem cells in vitro.
    Lian RH; Maeda M; Lohwasser S; Delcommenne M; Nakano T; Vance RE; Raulet DH; Takei F
    J Immunol; 2002 May; 168(10):4980-7. PubMed ID: 11994449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1(b).
    Vance RE; Kraft JR; Altman JD; Jensen PE; Raulet DH
    J Exp Med; 1998 Nov; 188(10):1841-8. PubMed ID: 9815261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
    Kamiya T; Seow SV; Wong D; Robinson M; Campana D
    J Clin Invest; 2019 May; 129(5):2094-2106. PubMed ID: 30860984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.